FDA Label for Glycopyrrolate

View Indications, Usage & Precautions

Glycopyrrolate Product Label

The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Package Label.Principal Display Panel



NDC 70771-1616-1

Glycopyrrolate Injection, USP

0.2 mg/mL

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

1 mL Single-Dose Vial

Rx only

NDC 70771-1616-7

Glycopyrrolate Injection, USP

0.2 mg/mL

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

25 x 1 mL Single-Dose Vials

Rx only

NDC 70771-1617-1

Glycopyrrolate Injection, USP

0.4 mg/2 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

2 mL Single-Dose Vial

Rx only

NDC 70771-1617-7

Glycopyrrolate Injection, USP

0.4 mg/2 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

25 x 2 mL Single-Dose Vials

Rx only

NDC 70771-1618-1

Glycopyrrolate Injection, USP

1 mg/5 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

5 mL Multiple-Dose Vial

Rx only

NDC 70771-1618-7

Glycopyrrolate Injection, USP

1 mg/5 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

25 x 5 mL Multiple-Dose Vials

Rx only

NDC 70771-1619-1

Glycopyrrolate Injection, USP

4 mg/20 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR

INTRAVENOUS ADMINISTRATION

20 mL Multiple-Dose Vial

Rx only

NDC 70771-1619-6

Glycopyrrolate Injection, USP

4 mg/20 mL

(0.2 mg/mL)

NOT FOR USE IN NEWBORNS

CONTAINS BENZYL ALCOHOL

FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION

10 x 20 mL Multiple-Dose Vials

Rx only


* Please review the disclaimer below.